Acadia Healthcare Company Inc
$ 15.53
13.69%
11 Feb - close price
- Market Cap 1,404,599,000 USD
- Current Price $ 15.53
- High / Low $ 15.80 / 13.30
- Stock P/E 11.77
- Book Value 34.51
- EPS 1.32
- Next Earning Report 2026-02-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.04 %
- 52 Week High 42.85
- 52 Week Low 11.43
About
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$19.07
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-07-29 | 2025-04-29 | 2025-02-25 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-27 | 2023-11-02 | 2023-07-27 | 2023-04-26 | 2023-02-27 |
| Reported EPS | 0.72 | 0.83 | 0.4 | 0.64 | 0.91 | 0.91 | 0.84 | 0.85 | 0.91 | 0.92 | 0.75 | 0.7 |
| Estimated EPS | 0.67 | 0.7044 | 0.357 | 0.7146 | 0.9 | 0.87 | 0.81 | 0.79 | 0.89 | 0.86 | 0.71 | 0.75 |
| Surprise | 0.05 | 0.1256 | 0.043 | -0.0746 | 0.01 | 0.04 | 0.03 | 0.06 | 0.02 | 0.06 | 0.04 | -0.05 |
| Surprise Percentage | 7.4627% | 17.8308% | 12.0448% | -10.4394% | 1.1111% | 4.5977% | 3.7037% | 7.5949% | 2.2472% | 6.9767% | 5.6338% | -6.6667% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-25 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ACHC
2026-02-06 09:29:37
Acadia Healthcare (ACHC) is gaining investor attention after cutting 2026 capital expenditures and facing pressure from activist shareholder Engine Capital for strategic review. Despite recent share price declines, the company's fair value is estimated at $19.07 against a current $13.55, suggesting it may be undervalued. The turnaround narrative hinges on capital discipline, reduced costs, and improved free cash flow generation.
2026-02-04 15:28:33
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Following the release, the company will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on the same day. A live webcast of the call will be available on Acadia Healthcare's website in the "Investors" section.
2026-02-03 23:28:33
Acadia Healthcare's (BIT:1ACHC) average one-year price target has been decreased by 11.12% to €16.86 per share, down from €18.97. This new target represents a potential 54.71% increase from its last closing price. Institutional ownership in Acadia Healthcare has also seen shifts, with major funds like Wellington Management Group Llp and Khrom Capital Management increasing their positions.
2026-02-03 22:59:14
Acadia Healthcare Company reappointed Debra K. Osteen as CEO following Christopher H. Hunter's departure, while activist investor Engine Capital is pressing for a strategic review, including a potential sale or share buybacks. This leadership change and activist pressure come amidst a significant stock decline, with shares trading at $13.21, down substantially over the past three years. Investors are now watching closely to see how the board will respond to the demands and what actions will be taken to improve returns and address operational concerns.
2026-02-03 12:28:43
Acadia Healthcare (NASDAQ:ACHC) has reappointed Debra K. Osteen as CEO following the departure of Christopher H. Hunter, amidst activist investor Engine Capital's call for a strategic review including a potential sale or significant share buybacks. The company's stock has seen substantial declines, dropping 70.5% over the past year and 83.5% over three years, intensifying pressure on the board to improve returns. Osteen's return, coupled with activist involvement, suggests a focus on operational stability and strategic actions to address financial performance.
2026-02-02 20:40:00
This article summarizes a bullish thesis on Acadia Healthcare Company, Inc. (ACHC), presenting it as a deep-value opportunity at distressed levels. Key drivers for potential upside include management's capex cuts leading to positive free cash flow, potential activist investor influence for strategic changes, and the resilience of the psychiatric facility industry despite legal risks. The stock is seen as an attractive "sin stock" with substantial upside and limited near-term downside.
